TCTMD -- Intracoronary bone marrow stem cell (BMC) therapy for chronic heart failure patients appears to provide multiple benefits, ranging from improved ventricular function to increased survival, according to results presented during a late-breaking trial session Sunday, August 29, 2010, at the European Society of Cardiology (ESC) Congress.
